戻る Agenda
Advancing Patient-centred Development and Access to Medicines in Partnership with Healthcare Systems
Session Chair(s)
Álmath Spooner, PhD
Director of Regulatory Policy and Intelligence
AbbVie, Ireland
Jordi Llinares Garcia, MS
Head of Research and Innovation
European Medicines Agency, Netherlands
The EU has led the world in patient engagement, but much is now also driven by FDA developing a framework for patient focused drug development. We will explore how EU developments can boost global progress and advance a roadmap for the region.
Learning Objective : To recognize important considerations to advance patient centered development and access to medicines in the EU from the perspective of key stakeholders in the topic. An improved understanding of how these different perspectives should be integrated to develop a workable roadmap for the EU.
Speaker(s)
Panelist
Elizabeth Vroom
Duchenne Parent Project, Netherlands
President
Panelist
Bruno Sepodes, PharmD, PhD, MPH, MSc
INFARMED, Portugal
Vice-Chair CHMP (EMA); Senior Expert INFARMED
Panelist
Irina Cleemput, PhD
Belgian Health Care Knowledge Centre (KCE), Belgium
Scientific Programme Director
Panelist
Mireille Muller, DrSc, PhD, MSc
Novartis Pharma AG, Switzerland
Regulatory Policy & Intelligence Director
Panelist
Sandra Kweder, MD
ELIQUENT Life Sciences, United States
Principal, Drug and Biological Products